Moreover, MALAT1 is one of the first identified cancer-associated lncRNAs; it is upregulated in several cancers, and its deregulation is considered a prognostic biomarker for particularly aggressive tumors (Hirata et al., 2015; Ma et al., 2015; Chen et al., 2017; Zhang X. et al., 2017; Li et al., 2018b; Sun and Ma, 2019). Here, MALAT1 is linked to cancer.